COLL vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

COLL

56.2
AI Score
VS
PCRX Wins

PCRX

58.6
AI Score

Investment Advisor Scores

COLL

56score
Recommendation
HOLD

PCRX

59score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric COLL PCRX Winner
Forward P/E 3.8775 8.726 COLL
PEG Ratio 0 11.2121 Tie
Revenue Growth 6.3% 6.2% COLL
Earnings Growth -46.6% -30.0% PCRX
Tradestie Score 56.2/100 58.6/100 PCRX
Profit Margin 5.9% 2.0% COLL
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY PCRX

Relative Price Performance (Last 90 Days)

COLL 1M: -23.8% · 3M: -21.2% PCRX 1M: -4.9% · 3M: +5.1%

Current Technical Phase

COLL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 32

RSI (14): 32.0 · Price: $27.11

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.5 · Price: $24.67

Fundamentals Snapshot

Metric COLL PCRX
Market Cap
Forward P/E 4.0 6.9
Trailing P/E 21.7 67.7
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.9% 0.8%
Operating Margin 0.1% 0.1%
EPS 1.27 0.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.